Cargando…
Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
BACKGROUND: Since more than two decades Risk-reducing salpingo-oophorectomy (RRSO) is recommended and widely accepted by BRCA1/2 carriers as a method reducing ovarian cancer risk and improving survival rate. After RRSO, there remains a risk of breast cancer and peritoneal cancer. The characteristics...
Autores principales: | Menkiszak, Janusz, Chudecka-Głaz, Anita, Cymbaluk-Płoska, Aneta, Celewicz, Aleksander, Kojs, Zbigniew, Szajda, Mariusz, Świniarska, Maria, Bedner, Ryszard, Jurczak, Anna, Celewicz, Marta, Cieszyńska, Monika, Lubiński, Jan, Gronwald, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419350/ https://www.ncbi.nlm.nih.gov/pubmed/30918533 http://dx.doi.org/10.1186/s13053-019-0109-5 |
Ejemplares similares
-
Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
por: Menkiszak, Janusz, et al.
Publicado: (2016) -
HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2017) -
Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016) -
Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2018) -
Ectopic pregnancy treatment by combination therapy
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2016)